Harrison.ai, a Sydney, Australia-based healthcare company focused on AI technologies, has completed a funding round worth $19.9 million (A$29 million).
Blackbird Ventures led the round, with additional contributions coming from Horizons Ventures, Skip Capital and Ramsay Healthcare. The money is expected to go toward hiring more employees to focus on data science and software engineering, according to a prepared statement. Funding will also be used to develop new AI applications related to “radiology, pathology and hospital operation.”
“I’m excited to be able to use my AI and medical background to help many thousands, potentially millions, of patients to achieve better healthcare outcomes faster than I ever could have by treating patients individually,” Aengus Tran, MD, Harrison.ai co-founder, said in the statement. “Wearing the dual hat of a clinician and an AI engineer translates into clinically sound designs and technically robust solutions to benefit patients.”
“Australia leads the world in many areas of healthcare,” Dimitry Tran, Harrison.ai co-founder, said in the same statement. “We have home-grown organizations that went on to become the world's largest in their domains such as Ramsay Health Care in hospital, Virtus Health in fertility and I-MED in radiology. This presents a great opportunity for technology development and global distribution. At Harrison.ai, a key part of our strategy moving forward is to collaborate with such organizations to develop AI-as-medical-device solutions that improve efficiency, accuracy and safety, ultimately enhancing patient outcomes.”
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.